Latest news
CMPS Stock Climbs After-Hours: Analyst Sees Depression Drug Approval By H1 2027 Or Sooner After Strong Trial Data - StocktwitsStocktwits · Sat, 08 Aug 2026 16:47:06 GMTONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study - StocktwitsStocktwits · Sat, 08 Aug 2026 15:22:42 GMTCMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial - StocktwitsStocktwits · Sat, 08 Aug 2026 13:44:19 GMTBiotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? - StocktwitsStocktwits · Sat, 08 Aug 2026 07:34:42 GMTCLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment - StocktwitsStocktwits · Sat, 08 Aug 2026 07:06:50 GMTERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - StocktwitsStocktwits · Sat, 08 Aug 2026 04:16:48 GMTOMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment - StocktwitsStocktwits · Sat, 08 Aug 2026 03:27:53 GMTMNKD Stock Jumps On Receiving FDA Approval For Afrezza To Treat Diabetes In Children - StocktwitsStocktwits · Fri, 07 Aug 2026 22:18:08 GMT